CA2900921A1 - Methods and compositions for nanostructure-based nucleic acid sequencing - Google Patents
Methods and compositions for nanostructure-based nucleic acid sequencing Download PDFInfo
- Publication number
- CA2900921A1 CA2900921A1 CA2900921A CA2900921A CA2900921A1 CA 2900921 A1 CA2900921 A1 CA 2900921A1 CA 2900921 A CA2900921 A CA 2900921A CA 2900921 A CA2900921 A CA 2900921A CA 2900921 A1 CA2900921 A1 CA 2900921A1
- Authority
- CA
- Canada
- Prior art keywords
- nucleic acid
- target nucleic
- acid molecule
- sequencing
- polymerase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000012163 sequencing technique Methods 0.000 title claims abstract description 215
- 239000002086 nanomaterial Substances 0.000 title claims abstract description 183
- 150000007523 nucleic acids Chemical class 0.000 title claims description 288
- 108020004707 nucleic acids Proteins 0.000 title claims description 286
- 102000039446 nucleic acids Human genes 0.000 title claims description 286
- 238000000034 method Methods 0.000 title claims description 121
- 239000000203 mixture Substances 0.000 title description 18
- 239000002777 nucleoside Substances 0.000 claims description 92
- -1 nucleoside triphosphate Chemical class 0.000 claims description 92
- 239000001226 triphosphate Substances 0.000 claims description 92
- 235000011178 triphosphate Nutrition 0.000 claims description 92
- 239000007787 solid Substances 0.000 claims description 85
- 230000033001 locomotion Effects 0.000 claims description 72
- 102000004190 Enzymes Human genes 0.000 claims description 69
- 108090000790 Enzymes Proteins 0.000 claims description 69
- 239000000758 substrate Substances 0.000 claims description 46
- 239000000872 buffer Substances 0.000 claims description 45
- 230000008859 change Effects 0.000 claims description 38
- 239000002773 nucleotide Substances 0.000 claims description 38
- 125000003729 nucleotide group Chemical group 0.000 claims description 38
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 claims description 33
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 claims description 30
- 239000003153 chemical reaction reagent Substances 0.000 claims description 27
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 25
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 25
- 238000004519 manufacturing process Methods 0.000 claims description 24
- 238000002360 preparation method Methods 0.000 claims description 20
- 239000000523 sample Substances 0.000 claims description 19
- 239000012472 biological sample Substances 0.000 claims description 14
- 101710137500 T7 RNA polymerase Proteins 0.000 claims description 12
- 239000012148 binding buffer Substances 0.000 claims description 9
- 241001515965 unidentified phage Species 0.000 claims description 9
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 8
- 239000002071 nanotube Substances 0.000 claims description 7
- 238000006116 polymerization reaction Methods 0.000 claims description 7
- 239000011534 wash buffer Substances 0.000 claims description 7
- 102000003960 Ligases Human genes 0.000 claims description 6
- 108090000364 Ligases Proteins 0.000 claims description 6
- 230000027455 binding Effects 0.000 claims description 6
- 241000588724 Escherichia coli Species 0.000 claims description 5
- 238000003776 cleavage reaction Methods 0.000 claims description 5
- 230000007017 scission Effects 0.000 claims description 5
- 239000010949 copper Substances 0.000 claims description 4
- 239000011521 glass Substances 0.000 claims description 4
- 108020004513 Bacterial RNA Proteins 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- 108010006785 Taq Polymerase Proteins 0.000 claims description 3
- 230000006037 cell lysis Effects 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000012139 lysis buffer Substances 0.000 claims description 3
- 239000002070 nanowire Substances 0.000 claims description 3
- 229910052759 nickel Inorganic materials 0.000 claims description 3
- 244000063299 Bacillus subtilis Species 0.000 claims description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 2
- 108010028263 bacteriophage T3 RNA polymerase Proteins 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 description 43
- 230000005945 translocation Effects 0.000 description 34
- 108020004414 DNA Proteins 0.000 description 17
- 239000011324 bead Substances 0.000 description 16
- 238000004590 computer program Methods 0.000 description 12
- 238000003860 storage Methods 0.000 description 11
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 10
- 229940098773 bovine serum albumin Drugs 0.000 description 10
- 239000012634 fragment Substances 0.000 description 10
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 10
- 230000008569 process Effects 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 8
- 238000013518 transcription Methods 0.000 description 8
- 230000035897 transcription Effects 0.000 description 8
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 238000010348 incorporation Methods 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 238000004891 communication Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 102000053602 DNA Human genes 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 230000001360 synchronised effect Effects 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 229910052710 silicon Inorganic materials 0.000 description 4
- 239000010703 silicon Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 230000005653 Brownian motion process Effects 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000012901 Milli-Q water Substances 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- 229910052581 Si3N4 Inorganic materials 0.000 description 3
- 108010090804 Streptavidin Proteins 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 238000005537 brownian motion Methods 0.000 description 3
- 230000001186 cumulative effect Effects 0.000 description 3
- 229910021389 graphene Inorganic materials 0.000 description 3
- 229920001519 homopolymer Polymers 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 238000010295 mobile communication Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 230000000644 propagated effect Effects 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 3
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- 241000203069 Archaea Species 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 238000001712 DNA sequencing Methods 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 102100031780 Endonuclease Human genes 0.000 description 2
- 241000206602 Eukaryota Species 0.000 description 2
- 108091006054 His-tagged proteins Proteins 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- JQGGAELIYHNDQS-UHFFFAOYSA-N Nic 12 Natural products CC(C=CC(=O)C)c1ccc2C3C4OC4C5(O)CC=CC(=O)C5(C)C3CCc2c1 JQGGAELIYHNDQS-UHFFFAOYSA-N 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- 101100273253 Rhizopus niveus RNAP gene Proteins 0.000 description 2
- 108091006629 SLC13A2 Proteins 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000009918 complex formation Effects 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000007306 functionalization reaction Methods 0.000 description 2
- 239000005350 fused silica glass Substances 0.000 description 2
- 238000012268 genome sequencing Methods 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 238000000813 microcontact printing Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 150000003833 nucleoside derivatives Chemical class 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000013515 script Methods 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- SYFQYGMJENQVQT-ZETCQYMHSA-N (2s)-6-amino-2-[bis(carboxymethyl)amino]hexanoic acid Chemical compound NCCCC[C@@H](C(O)=O)N(CC(O)=O)CC(O)=O SYFQYGMJENQVQT-ZETCQYMHSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241001137853 Crenarchaeota Species 0.000 description 1
- 241000938605 Crocodylia Species 0.000 description 1
- 241000270722 Crocodylidae Species 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
- 241000701867 Enterobacteria phage T7 Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241001137858 Euryarchaeota Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101001042038 Homo sapiens Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial Proteins 0.000 description 1
- 101000901226 Homo sapiens S-arrestin Proteins 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- 102100021311 Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial Human genes 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 239000012807 PCR reagent Substances 0.000 description 1
- 102100024380 Poly(A) RNA polymerase GLD2 Human genes 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 238000012181 QIAquick gel extraction kit Methods 0.000 description 1
- 108010013845 RNA Polymerase I Proteins 0.000 description 1
- 102000017143 RNA Polymerase I Human genes 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 102100022135 S-arrestin Human genes 0.000 description 1
- 101000677220 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L33-A Proteins 0.000 description 1
- 101000677235 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L33-B Proteins 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- LDDQLRUQCUTJBB-UHFFFAOYSA-N ammonium fluoride Chemical compound [NH4+].[F-] LDDQLRUQCUTJBB-UHFFFAOYSA-N 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 150000001615 biotins Chemical class 0.000 description 1
- 239000005388 borosilicate glass Substances 0.000 description 1
- 238000004422 calculation algorithm Methods 0.000 description 1
- 239000002041 carbon nanotube Substances 0.000 description 1
- 229910021393 carbon nanotube Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000000979 dip-pen nanolithography Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000012165 high-throughput sequencing Methods 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine Substances NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 229920001427 mPEG Polymers 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000012634 optical imaging Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000002161 passivation Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000005019 pattern of movement Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 108010018381 streptavidin-binding peptide Proteins 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- BPSIOYPQMFLKFR-UHFFFAOYSA-N trimethoxy-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CO[Si](OC)(OC)CCCOCC1CO1 BPSIOYPQMFLKFR-UHFFFAOYSA-N 0.000 description 1
- 230000005641 tunneling Effects 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361766925P | 2013-02-20 | 2013-02-20 | |
| US61/766,925 | 2013-02-20 | ||
| PCT/US2014/017419 WO2014130686A2 (en) | 2013-02-20 | 2014-02-20 | Methods and compositions for nanostructure-based nucleic acid sequencing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2900921A1 true CA2900921A1 (en) | 2014-08-28 |
Family
ID=51351616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2900921A Abandoned CA2900921A1 (en) | 2013-02-20 | 2014-02-20 | Methods and compositions for nanostructure-based nucleic acid sequencing |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US9725763B2 (enExample) |
| EP (1) | EP2958927A4 (enExample) |
| JP (1) | JP2016507249A (enExample) |
| KR (1) | KR20150119353A (enExample) |
| CN (1) | CN105308062A (enExample) |
| AU (1) | AU2014218911B2 (enExample) |
| CA (1) | CA2900921A1 (enExample) |
| HK (1) | HK1221227A1 (enExample) |
| RU (1) | RU2015139609A (enExample) |
| WO (1) | WO2014130686A2 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3848706B1 (en) | 2011-05-27 | 2023-07-19 | Oxford Nanopore Technologies PLC | Coupling method |
| EP2994544B1 (en) | 2013-05-06 | 2019-10-02 | Pacific Biosciences Of California, Inc. | Real-time electronic sequencing |
| GB201406155D0 (en) | 2014-04-04 | 2014-05-21 | Oxford Nanopore Tech Ltd | Method |
| US10337060B2 (en) | 2014-04-04 | 2019-07-02 | Oxford Nanopore Technologies Ltd. | Method for characterising a double stranded nucleic acid using a nano-pore and anchor molecules at both ends of said nucleic acid |
| GB201418469D0 (en) | 2014-10-17 | 2014-12-03 | Oxford Nanopore Tech Ltd | Method |
| WO2017024017A1 (en) | 2015-08-06 | 2017-02-09 | Pacific Biosciences Of California, Inc. | Systems and methods for selectively addressing sparsely arranged electronic measurement devices |
| CN105170209B (zh) * | 2015-10-15 | 2017-05-10 | 华中科技大学 | 一种表面图案化修饰的基片及其制备方法 |
| WO2017132586A1 (en) * | 2016-01-28 | 2017-08-03 | Roswell Biotechnologies, Inc. | Methods and apparatus for measuring analytes using large scale molecular electronics sensor arrays |
| KR102184637B1 (ko) * | 2016-08-04 | 2020-11-30 | 연세대학교 원주산학협력단 | 퀀타매트릭스 어세이 플랫폼 기반 결핵 및 비결핵 항산균의 검출 및 동정과 결핵균의 리팜핀 내성여부를 동시 확인할 수 있는 진단법 및 그 키트 |
| CN106244712B (zh) * | 2016-08-31 | 2019-11-19 | 北京大学 | Dna测序方法 |
| CN110520517A (zh) * | 2017-01-19 | 2019-11-29 | 罗斯威尔生命技术公司 | 包括二维层材料的固态测序装置 |
| JP6559814B2 (ja) * | 2018-01-26 | 2019-08-14 | 株式会社日立ハイテクノロジーズ | 生体分子測定方法 |
| EP3987052A4 (en) * | 2019-06-18 | 2023-07-26 | Illumina, Inc. | ATTACHING POLYMERASE TO A CONDUCTIVE CHANNEL |
| CN110452817A (zh) * | 2019-07-08 | 2019-11-15 | 广东工业大学 | 一种dna测序装置及测序方法 |
| CN111455034B (zh) * | 2020-04-09 | 2024-04-09 | 苏州罗岛纳米科技有限公司 | 一种基于固态纳米孔机构的单分子检测方法和系统 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5693489A (en) | 1984-03-30 | 1997-12-02 | Associated Universities, Inc. | Cloning and expression of the gene for bacteriophage T7 RNA polymerase |
| US5795782A (en) * | 1995-03-17 | 1998-08-18 | President & Fellows Of Harvard College | Characterization of individual polymer molecules based on monomer-interface interactions |
| US20020172953A1 (en) * | 1996-07-29 | 2002-11-21 | Mirkin Chad A. | Movement of biomolecule-coated nanoparticles in an electric field |
| WO2000036151A1 (en) | 1998-12-14 | 2000-06-22 | Li-Cor, Inc. | A heterogeneous assay for pyrophosphate detection |
| US6529240B2 (en) | 1999-11-18 | 2003-03-04 | Agilent Technologies, Inc. | Random access memory integrated with CMOS sensors |
| US7238477B2 (en) * | 2001-09-24 | 2007-07-03 | Intel Corporation | Methods to increase nucleotide signals by Raman scattering |
| DE602004021235D1 (de) * | 2003-02-21 | 2009-07-09 | Geneform Technologies Ltd | Verfahren, kits und reagenzien zur nukleinsäuresequenzierung |
| US20070077575A1 (en) | 2004-03-05 | 2007-04-05 | Mcallister William T | Use of rna polymerase as an information-dependent molecular motor |
| WO2006028508A2 (en) * | 2004-03-23 | 2006-03-16 | President And Fellows Of Harvard College | Methods and apparatus for characterizing polynucleotides |
| US7556922B2 (en) * | 2006-03-23 | 2009-07-07 | The Board Of Trustees Of The Leland Stanford Junior University | Motion resolved molecular sequencing |
| US8500982B2 (en) * | 2007-04-04 | 2013-08-06 | The Regents Of The University Of California | Compositions, devices, systems, and methods for using a nanopore |
| US9395352B2 (en) * | 2007-04-06 | 2016-07-19 | Arizona Board Of Regents On Behalf Of Arizona State University | Devices and methods for target molecule characterization |
| US20090208957A1 (en) | 2007-12-04 | 2009-08-20 | Pacific Biosciences Of California, Inc. | Alternate labeling strategies for single molecule sequencing |
| US8815576B2 (en) | 2007-12-27 | 2014-08-26 | Lawrence Livermore National Security, Llc. | Chip-based sequencing nucleic acids |
| WO2009117522A2 (en) * | 2008-03-18 | 2009-09-24 | Reinhart, Kevin | Nanopore and carbon nanotube based dna sequencer and a serial recognition sequencer |
| US20100255487A1 (en) * | 2009-03-27 | 2010-10-07 | Life Technologies Corporation | Methods and apparatus for single molecule sequencing using energy transfer detection |
| US9017937B1 (en) * | 2009-04-10 | 2015-04-28 | Pacific Biosciences Of California, Inc. | Nanopore sequencing using ratiometric impedance |
| ES2892158T3 (es) * | 2010-02-23 | 2022-02-02 | Univ Washington | Membranas artificiales de ácidos micólicos |
| CN103392008B (zh) * | 2010-09-07 | 2017-10-20 | 加利福尼亚大学董事会 | 通过持续性酶以一个核苷酸的精度控制dna在纳米孔中的移动 |
| ES2641871T3 (es) * | 2010-12-17 | 2017-11-14 | The Trustees Of Columbia University In The City Of New York | Secuenciación de ADN mediante síntesis usando nucleótidos modificados y detección con nanoporos |
| WO2012116191A1 (en) * | 2011-02-23 | 2012-08-30 | Eve Biomedical, Inc. | Rotation-dependent transcriptional sequencing systems and methods of using |
| EP3848706B1 (en) * | 2011-05-27 | 2023-07-19 | Oxford Nanopore Technologies PLC | Coupling method |
| BR112014001699A2 (pt) * | 2011-07-25 | 2017-06-13 | Oxford Nanopore Tech Ltd | método para sequenciar de um polinucleotídeo alvo de filamento duplo, kit, métodos para preparar um polinucleotídeo alvo de filamento duplo para sequenciamento e para sequenciar um polinucleotídeo alvo de filamento duplo, e, aparelho |
| US9164053B2 (en) * | 2011-09-26 | 2015-10-20 | The Regents Of The University Of California | Electronic device for monitoring single molecule dynamics |
| US9279154B2 (en) * | 2011-12-21 | 2016-03-08 | Illumina, Inc. | Apparatus and methods for kinetic analysis and determination of nucleic acid sequences |
| GB2557509A (en) * | 2012-06-08 | 2018-06-20 | Pacific Biosciences California Inc | Modified base detection with nanopore sequencing |
| US20140147833A1 (en) * | 2012-11-28 | 2014-05-29 | International Business Machines Corporation | Base recognition based on the conformation change of a motor molecule |
-
2014
- 2014-02-20 CA CA2900921A patent/CA2900921A1/en not_active Abandoned
- 2014-02-20 JP JP2015558959A patent/JP2016507249A/ja active Pending
- 2014-02-20 RU RU2015139609A patent/RU2015139609A/ru not_active Application Discontinuation
- 2014-02-20 AU AU2014218911A patent/AU2014218911B2/en not_active Ceased
- 2014-02-20 WO PCT/US2014/017419 patent/WO2014130686A2/en not_active Ceased
- 2014-02-20 CN CN201480022008.6A patent/CN105308062A/zh active Pending
- 2014-02-20 EP EP14754640.2A patent/EP2958927A4/en not_active Withdrawn
- 2014-02-20 KR KR1020157025411A patent/KR20150119353A/ko not_active Withdrawn
- 2014-02-20 HK HK16109275.9A patent/HK1221227A1/zh unknown
- 2014-02-20 US US14/185,469 patent/US9725763B2/en active Active
-
2017
- 2017-08-02 US US15/666,671 patent/US20180010181A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HK1221227A1 (zh) | 2017-05-26 |
| AU2014218911A1 (en) | 2015-08-27 |
| US20180010181A1 (en) | 2018-01-11 |
| WO2014130686A3 (en) | 2014-10-09 |
| AU2014218911B2 (en) | 2018-07-12 |
| RU2015139609A (ru) | 2017-03-24 |
| WO2014130686A2 (en) | 2014-08-28 |
| JP2016507249A (ja) | 2016-03-10 |
| CN105308062A (zh) | 2016-02-03 |
| EP2958927A2 (en) | 2015-12-30 |
| US9725763B2 (en) | 2017-08-08 |
| US20140235462A1 (en) | 2014-08-21 |
| EP2958927A4 (en) | 2016-09-14 |
| KR20150119353A (ko) | 2015-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2014218911B2 (en) | Methods and compositions for nanostructure-based nucleic acid sequencing | |
| US10988760B2 (en) | Sample preparation on a solid support | |
| KR101924665B1 (ko) | 회전-의존성 전사 서열분석 시스템 및 사용 방법 | |
| JP7055805B2 (ja) | ナノポアを用いて検体を特徴付けるための方法及びシステム | |
| CN109312401B (zh) | 连接的核酸的纳米孔测序方法 | |
| CN114107457B (zh) | 向跨膜孔输送分析物的方法 | |
| EP3802877B1 (en) | Method | |
| HK40114869A (en) | Sample preparation on a solid support | |
| HK40096585A (zh) | 多路复用covid-19锁式测定 | |
| HK40007783A (en) | Sample preparation on a solid support | |
| HK1187959B (en) | Rotation-dependent transcriptional sequencing systems and methods of using |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |
Effective date: 20200220 |